… associated with new oral contraceptives containing desogestrel … , those receiving older
contraceptives had been using them … desogestrel and gestodene contraceptives have a sixfold to …

… ) and attributable risks (ARs) of cardiovascular disease (CVD), cancer, and other health
outcomes associated with use of oral contraceptives (OCs) and menopausal hormone therapy (…

… In the US, hormone therapy delivered as oral contraceptives (OCs) is one of the most …
age-adjusted risk of cardiovascular disease compared with men. Cardiovascular risk rises after …

… of oral contraceptives on risks of cardiovascular diseases … 55 years old and free of coronary
disease or stroke in 1976, They … coronary disease, 282 strokes, and 48 other cardiovascular …

… metabolism and oral contraceptive use in the development of cardiovascular disease is briefly
… , to assess the effect of different oral contraceptive formulations on serum lipid levels. The …

… that bears on the cardiovascular safety of combined oral contraceptives containing second-
… oral contraceptives are safer than earlier formulations with respect to cardiovascular disease…

… past use of oral contraceptive agents on the risk of various cardiovascular diseases among
women in … on their use of oral contraceptives, and who at entry had had no previous coronary …

… the relationship between oral contraceptive use and each of these cardiovascular
complications. In addition, the relative and actual risk of each of these cardiovascular diseases is …

… Cardiovascular risks have been a concern since combined oral contraceptives (OCs) were
… dose OCs are very small in women without cardiovascular risk factors, while increased risk of …

… contraceptive effectivity as the combined oral contraceptives. It is therefore the only
progesterone-only pill recommended in women with (severe) cardiac disease. … offers contraceptive …